Clinical basis for the development of neuroprotective therapy in acute ischemic stroke

In recent years, the incidence of ischemic stroke has increased everywhere. This fact is explained by the increase in the number of elderly people and the prevalence of risk factors for stroke, such as arterial hypertension, diabetes, obesity, heart disease, etc., more than 80% of survivors are disabled. To date, neuroprotective therapy is the most important treatment in the treatment of this disease, and this article really describes its improving properties.

Перевод пока недоступен